An integrated map of genetic variation from 1,092 human genomes, Genomes Project Consortium, vol.491, pp.56-65, 2012. ,
AACR Project GENIE: Powering Precision Medicine through an International Consortium, Cancer Discov, vol.7, pp.818-831, 2017. ,
Redefining malignant pleural mesothelioma types as a continuum uncovers immune-vascular interactions, EBioMedicine, vol.48, pp.191-202, 2019. ,
Five years update on relationships between malignant pleural mesothelioma and exposure to asbestos and other elongated mineral particles, J Toxicol Environ Health B Crit Rev, vol.19, pp.151-172, 2016. ,
URL : https://hal.archives-ouvertes.fr/inserm-02478603
Neurofibromatosis 2 (NF2) and malignant mesothelioma in a man with a constitutional NF2 missense mutation, Fam Cancer, vol.4, pp.321-322, 2005. ,
Dissecting heterogeneity in malignant pleural mesothelioma through histo-molecular gradients for clinical applications, Nat Commun, vol.10, p.1333, 2019. ,
URL : https://hal.archives-ouvertes.fr/hal-02090279
Genome-wide analysis of abdominal and pleural malignant mesothelioma with DNA arrays reveals both common and distinct regions of copy number alteration, Cancer Biol Ther, vol.17, pp.328-335, 2016. ,
Comprehensive genomic analysis of malignant pleural mesothelioma identifies recurrent mutations, gene fusions and splicing alterations, Nat Genet, vol.48, pp.407-416, 2016. ,
Histological subtypes of hepatocellular carcinoma are related to gene mutations and molecular tumour classification, J Hepatol, vol.67, pp.727-738, 2017. ,
The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data, Cancer Discov, vol.2, pp.401-404, 2012. ,
Molecular classification of malignant pleural mesothelioma: identification of a poor prognosis subgroup linked to the epithelial-to-mesenchymal transition, Clin Cancer Res, vol.20, pp.1323-1334, 2014. ,
URL : https://hal.archives-ouvertes.fr/inserm-02478599
GeneSrF and varSelRF: a web-based tool and R package for gene selection and classification using random forest, BMC Bioinformatics, vol.8, p.328, 2007. ,
Binimetinib versus dacarbazine in patients with advanced NRAS-mutant melanoma (NEMO): a multicentre, open-label, randomised, Lancet Oncol, vol.18, pp.435-445, 2017. ,
Hippo/YAP pathway for targeted therapy, Transl Lung Cancer Res, vol.3, pp.75-83, 2014. ,
, , 1998.
, Annales de pathologie, vol.34, pp.51-63
Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal, Sci Signal, vol.6, p.1, 2013. ,
Conditional biallelic Nf2 mutation in the mouse promotes manifestations of human neurofibromatosis type 2, Genes Dev, vol.14, pp.1617-1630, 2000. ,
Whole-exome sequencing reveals frequent genetic alterations in BAP1, NF2, CDKN2A, and CUL1 in malignant pleural mesothelioma, Cancer Res, vol.75, pp.264-269, 2015. ,
Integrative Molecular Characterization of Malignant Pleural Mesothelioma, Cancer Discov, vol.8, pp.1548-1565, 2018. ,
Using Somatic Mutations to Guide Treatment Decisions: Context Matters, JAMA Oncol, vol.1, pp.275-276, 2015. ,
Recurrent TERT promoter mutations identified in a large-scale study of multiple tumour types are associated with increased TERT expression and telomerase activation, Eur J Cancer, vol.51, pp.969-976, 2015. ,
The molecular pathology of cancer: from pan-genomics to postgenomics, J Pathol, vol.244, pp.509-511, 2018. ,
Guidelines for pathologic diagnosis of malignant mesothelioma: 2012 update of the consensus statement from the International Mesothelioma Interest Group, Arch Pathol Lab Med, vol.137, pp.647-667, 2013. ,
Molecular changes in mesothelioma with an impact on prognosis and treatment, Arch Pathol Lab Med, vol.136, pp.277-293, 2012. ,
URL : https://hal.archives-ouvertes.fr/inserm-02478588
Syntenic Relationships between Genomic Profiles of Fiber-Induced Murine and Human Malignant Mesothelioma, Am J Pathol, vol.178, pp.881-894, 2011. ,
URL : https://hal.archives-ouvertes.fr/inserm-00531343
A conditional mouse model for malignant mesothelioma, Cancer Cell, vol.13, pp.261-271, 2008. ,
Analysis of protein-coding genetic variation in 60,706 humans, Nature, vol.536, pp.285-291, 2016. ,
Fast and accurate short read alignment with Burrows-Wheeler transform, Bioinformatics, vol.25, pp.1754-1760, 2009. ,
The Sequence Alignment/Map format and SAMtools, Genome Project Data Processing, vol.25, pp.2078-2079, 2009. ,
Functional role of SETD2, BAP1, PARP-3 and PBRM1 candidate genes on the regulation of hTERT gene expression, Oncotarget, vol.8, pp.61890-61900, 2017. ,
The prognostic significance of TERT promoter mutations in meningioma: a systematic review and meta-analysis, J Neurooncol, vol.142, pp.1-10, 2019. ,
Maftools: efficient and comprehensive analysis of somatic variants in cancer, Genome Res, vol.28, pp.1747-1756, 2018. ,
Low Merlin expression and high Survivin labeling index are indicators for poor prognosis in patients with malignant pleural mesothelioma, Mol Oncol, vol.10, pp.1255-1265, 2016. ,
Frequency of Germline Mutations in Cancer Susceptibility Genes in Malignant Mesothelioma, J Clin Oncol, vol.36, pp.2863-2871, 2018. ,
A Subset of Mesotheliomas With Improved Survival Occurring in Carriers of BAP1 and Other Germline Mutations, J Clin Oncol. JCO2018790352, 2018. ,
TERT biology and function in cancer: beyond immortalisation, J Mol Endocrinol, vol.58, pp.129-146, 2017. ,
Oncotator: cancer variant annotation tool, Hum Mutat, vol.36, pp.2423-2429, 2015. ,
NF2/Merlin Inactivation and Potential Therapeutic Targets in Mesothelioma, Int J Mol Sci, vol.19, p.988, 2018. ,
First-in-Class ERK1/2 Inhibitor Ulixertinib (BVD-523) in Patients with MAPK Mutant Advanced Solid Tumors: Results of a Phase I Dose-Escalation and Expansion Study, Cancer Discov, vol.8, pp.184-195, 2018. ,
Overexpression and promoter mutation of the TERT gene in malignant pleural mesothelioma, Oncogene, vol.33, pp.3748-3752, 2014. ,
URL : https://hal.archives-ouvertes.fr/inserm-02478602
COSMIC: the Catalogue Of Somatic Mutations In Cancer, Nucleic Acids Res, vol.47, pp.941-947, 2019. ,
Co-occurring mutations of tumor suppressor genes, LATS2 and NF2, in malignant pleural mesothelioma, Clin Cancer Res, vol.23, pp.3191-3202, 2017. ,
URL : https://hal.archives-ouvertes.fr/inserm-02478604
Primer3--new capabilities and interfaces, Nucleic Acids Res, vol.40, p.115, 2012. ,
Comprehensive Study of the Clinical Phenotype of Germline BAP1 Variant-Carrying Families Worldwide, J Natl Cancer Inst, vol.110, pp.1328-1341, 2018. ,
ANNOVAR: functional annotation of genetic variants from highthroughput sequencing data, Nucleic Acids Res, vol.38, p.164, 2010. ,
High-density array-CGH with targeted NGS unmask multiple noncontiguous minute deletions on chromosome 3p21 in mesothelioma, Proc Natl Acad Sci U S A, vol.113, pp.13432-13437, 2016. ,
Biallelic germline and somatic mutations in malignant mesothelioma: multiple mutations in transcription regulators including mSWI/SNF genes, Int J Cancer, vol.136, pp.560-571, 2015. ,
In vitro effects of recombinant human interferon gamma on human mesothelioma cell lines, Int J Cancer, vol.55, pp.515-520, 1993. ,